These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 6975136

  • 21. Inhibition of adenosine deaminase leads to enhanced antibody responses in the mouse.
    Nicholson JK, Gordon DS, McDougal JS.
    Cell Immunol; 1983 Jul 15; 79(2):320-33. PubMed ID: 6347398
    [Abstract] [Full Text] [Related]

  • 22. The effects of an induced adenosine deaminase deficiency on T-cell differentiation in the rat.
    Barton RW.
    Cell Immunol; 1985 Oct 15; 95(2):297-310. PubMed ID: 3876160
    [Abstract] [Full Text] [Related]

  • 23. In vivo inhibition of adenosine deaminase by 2'-deoxycoformycin in mouse blood and leukemia L1210 cells.
    Agarwal RP.
    Biochem Pharmacol; 1980 Feb 15; 29(2):187-93. PubMed ID: 6965857
    [No Abstract] [Full Text] [Related]

  • 24. Transport of deoxycoformycin in human erythrocytes. Measurement by adenosine deaminase titration and radioisotope assays.
    Chen SF, Stoeckler JD, Parks RE.
    Biochem Pharmacol; 1984 Dec 15; 33(24):4069-79. PubMed ID: 6334522
    [Abstract] [Full Text] [Related]

  • 25. Effects of deoxycoformycin in mice. II. Differences between the drug sensitivities and purine metabolizing enzymes of transplantable lymphomas of varying immunologic phenotypes.
    Ratech H, Kim J, Asofsky R, Thorbecke GJ, Hirschhorn R.
    J Immunol; 1984 Jun 15; 132(6):3077-84. PubMed ID: 6202772
    [Abstract] [Full Text] [Related]

  • 26. Animal model for immune dysfunction associated with adenosine deaminase deficiency.
    Tedde A, Balis ME, Ikehara S, Pahwa R, Good RA, Trotta PP.
    Proc Natl Acad Sci U S A; 1980 Aug 15; 77(8):4899-903. PubMed ID: 6968908
    [Abstract] [Full Text] [Related]

  • 27. Hemolysis in mice treated with deoxycoformycin, an inhibitor of adenosine deaminase.
    Smith CM, Belch A, Henderson JF.
    Biochem Pharmacol; 1980 Apr 15; 29(8):1209-10. PubMed ID: 6966932
    [No Abstract] [Full Text] [Related]

  • 28. ATP depletion as a consequence of adenosine deaminase inhibition in man.
    Siaw MF, Mitchell BS, Koller CA, Coleman MS, Hutton JJ.
    Proc Natl Acad Sci U S A; 1980 Oct 15; 77(10):6157-61. PubMed ID: 6969403
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Deoxyadenosine triphosphate accumulation in erythrocytes of deoxycoformycin-treated mice.
    Smith CM, Henderson JF.
    Biochem Pharmacol; 1982 Apr 15; 31(8):1545-51. PubMed ID: 6980005
    [Abstract] [Full Text] [Related]

  • 33. Energy metabolism in adenosine deaminase-inhibited human erythrocytes.
    Buc HA, Thuillier L, Hamet M, Garreau F, Moncion A, Pérignon JL.
    Clin Chim Acta; 1986 Apr 15; 156(1):61-9. PubMed ID: 3486057
    [Abstract] [Full Text] [Related]

  • 34. Role of nucleoside transport in drug action. The adenosine deaminase inhibitor, deoxycoformycin, and the antiplatelet drugs, dipyridamole and dilazep.
    Parks RE, Dawicki DD, Agarwal KC, Chen SF, Stoeckler JD.
    Ann N Y Acad Sci; 1985 Apr 15; 451():188-203. PubMed ID: 3878117
    [No Abstract] [Full Text] [Related]

  • 35. Comparison of the activity of 2'-deoxycoformycin and erythro-9-(2-hydroxy-3-nonyl)adenine in vivo.
    Plunkett W, Alexander L, Chubb S, Loo TL.
    Biochem Pharmacol; 1979 Apr 15; 28(2):201-6. PubMed ID: 426835
    [No Abstract] [Full Text] [Related]

  • 36. Adenosine deaminase inhibitors enhance cerebral anoxic hyperemia in the rat.
    Phillis JW, DeLong RE, Towner JK.
    J Cereb Blood Flow Metab; 1985 Jun 15; 5(2):295-9. PubMed ID: 3872875
    [Abstract] [Full Text] [Related]

  • 37. Metabolic abnormalities of human adenosine deaminase deficiency reproduced in the mouse by 2'-deoxycoformycin, and adenosine deaminase inhibitor.
    Ratech H, Thorbecke GJ, Hirschhorn R.
    Clin Immunol Immunopathol; 1981 Oct 15; 21(1):119-27. PubMed ID: 6268339
    [No Abstract] [Full Text] [Related]

  • 38. Adenosine and hypoxic vasodilatation.
    Dóra E.
    J Cereb Blood Flow Metab; 1985 Dec 15; 5(4):621-4. PubMed ID: 3877069
    [No Abstract] [Full Text] [Related]

  • 39. dATP-mediated inhibition of DNA ligase by 2'-deoxycoformycin in T and B cell leukemia.
    Lamballe F, Le Prise PY, Le Gall E, David JC.
    Leukemia; 1989 Feb 15; 3(2):97-103. PubMed ID: 2783473
    [Abstract] [Full Text] [Related]

  • 40. Effects of adenosine deaminase inhibitor 2'-deoxycoformycin on the repair and expression of potentially lethal damage sensitive to beta-araA.
    Iliakis G, Ngo FQ.
    Radiat Environ Biophys; 1985 Feb 15; 24(2):81-8. PubMed ID: 3874406
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.